Record overview
Status and phase
Status: COMPLETED
Phase: PHASE1, PHASE2
Sponsor: Compugen Ltd
Condition: Endometrial Neoplasms, Ovarian Cancer, Solid Tumor, Head and Neck Cancer
NCT04570839
COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Completed No Results Found Signal
Operational burden: strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.